METiS TechBio has teamed up with Lilly in a deal worth $1.1bn, pairing AI-driven lipid design with pharma expertise to ...
The UK Medicines and Healthcare products Regulatory Agency will develop an AI protocol checker to help clinical trial sponsors.
Europe's clinical trial numbers have fallen 13.5% annually since 2013, with late-stage and non-commercial trials declining.
BioXconomy highlights leading Black innovators and leaders in the biotechnology industry.
Germany’s Merck has agreed to acquire London-based Silence Therapeutics in an all-cash deal, adding a late-stage rare blood ...
IQVIA and Veeva extend their partnership, expanding sponsor access to Veeva's clinical trial and data management technology.
The clinical-stage biotech has closed an oversubscribed Series D financing round in a bid to meeting its mission to stop ...
Estuary Biotherapeutics launches with $103 million to take gene therapies for kidney disease into the clinic. The financing ...
Labcorp acquires BioReference Health assets from OPKO for $722 million, expanding reach of its FDA-approved 4Kscore prostate ...
Biopharma finance leaders detail how they build and refine gross-to-net models amid shrinking margins across biopharma ...
AstraZeneca pays $40 million upfront to put insitro's AI platform to work on metabolic dysfunction-associated steatohepatitis ...
Zealand Pharma has signed a multi-target collaboration with Generate Biomedicines to design protein therapeutics for obesity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results